Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up

Recruiting now

Conditions studied: Osteoarthritis, Hip, Hip Osteoarthritis, Prosthesis Survival, Prosthesis Failure

In brief

The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results. The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.

Key facts

Study ID

NCT04688593

Run by

Waldemar Link GmbH & Co. KG

People needed

520

Starts

2021-05-04

Expected to finish

2036-01-01

Last updated by the study team

2024-01-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link
• Age ≥ 18 years
• Fully signed patient informed cons

You may not qualify if…

• Revisions
• Body Mass Index (BMI) ≥ 40 kg/m²
• Patient who is foreseeable not able to understand the study and the study-related circumstances
• Patients who is foreseeable non-compliant to the treatment and the follow-ups
• Pregnant or breast-feeding women
• Prisoner

Where it is running

• Lubinus Stiftung — Kiel, Germany (enrolling)
• NHS FIFE Victoria Hospital — Kirkcaldy, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.